FDA approves first treatment for pediatric functional constipation

[FDA]

FDA has approved Linzess (linaclotide) capsules to treat functional constipation in pediatric patients 6 to 17 years of age. Linzess is the first treatment for pediatric functional constipation. The recommended dosage in pediatric patients 6 to 17 years is 72 mcg orally once daily.


Baca selengkapnya di : http://www.fda.gov...